Skye Bioscience, Inc. (SKYE) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
11250 El Camino Real
San Diego, CA 92130
United States of America (the)
Phone
858 410 0266
Website
Sector
Healthcare
Industry
Biotechnology
Employees
12
First IPO Date
January 06, 2015
| Name | Title | Pay | Year Born |
| Punit S. Dhillon | President, CEO & Director | 829,600 | 1980 |
| Tu Diep | Chief Operating Officer | 556,600 | 1981 |
| Christopher G. Twitty | Chief Scientific Officer | 0 | 1972 |
| Puneet S. Arora FACE | Chief Medical Officer | 0 | 1972 |
| John Sharp | CFO and Principal Financial & Accounting Officer | 0 | 1965 |
Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. is headquartered in San Diego, California.